Current and future influenza vaccines
Top Cited Papers
- 28 January 2019
- journal article
- review article
- Published by Springer Nature in Nature Medicine
- Vol. 25 (2) , 212-220
- https://doi.org/10.1038/s41591-018-0340-z
Abstract
Although antiviral drugs and vaccines have reduced the economic and healthcare burdens of influenza, influenza epidemics continue to take a toll. Over the past decade, research on influenza viruses has revealed a potential path to improvement. The clues have come from accumulated discoveries from basic and clinical studies. Now, virus surveillance allows researchers to monitor influenza virus epidemic trends and to accumulate virus sequences in public databases, which leads to better selection of candidate viruses for vaccines and early detection of drug-resistant viruses. Here we provide an overview of current vaccine options and describe efforts directed toward the development of next-generation vaccines. Finally, we propose a plan for the development of an optimal influenza vaccine.Keywords
This publication has 132 references indexed in Scilit:
- Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in HumansClinical Infectious Diseases, 2012
- Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza virusesProceedings of the National Academy of Sciences, 2011
- Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutininProceedings of the National Academy of Sciences, 2011
- Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infectionThe Journal of Experimental Medicine, 2011
- Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypesProceedings of the National Academy of Sciences, 2010
- In vitro and in vivo characterization of new swine-origin H1N1 influenza virusesNature, 2009
- Emergence and pandemic potential of swine-origin H1N1 influenza virusNature, 2009
- FluBlok, a next generation influenza vaccine manufactured in insect cellsBiologicals, 2009
- Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolutionNature, 1981
- The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B virusesEpidemiology and Infection, 1972